Fig. 3.

Incremental net monetary benefit of shifting from the 2-visit strategy to the 1-visit strategy. Incremental net monetary benefit (INMB) (in 2011 international dollars, y-axis) is displayed for each country as loss to follow-up (LTFU) per health facility visit is varied from 10% to 70% (x-axis), assuming a willingness-to-pay threshold equivalent to each country’s GDP per capita. For the 2-visit strategy, LTFU applied to the results/cryotherapy visit, as well as subsequent visits for diagnostic confirmation and treatment among women who were ineligible for cryotherapy in a screen-and-treat approach. For the 1-visit screen-and-treat strategy, LTFU only applied to diagnostic confirmation and treatment visits among women who were ineligible for immediate cryotherapy. The INMB for 1-visit HPV testing (relative to 2-visit HPV testing) for India is represented by the blue line, Nicaragua by the red line, and Uganda by the green line